123 related articles for article (PubMed ID: 26238659)
21. Resveratrol inhibits high-glucose-induced inflammatory "metabolic memory" in human retinal vascular endothelial cells through SIRT1-dependent signaling.
Jiang T; Gu J; Chen W; Chang Q
Can J Physiol Pharmacol; 2019 Dec; 97(12):1141-1151. PubMed ID: 31638409
[TBL] [Abstract][Full Text] [Related]
22. Notch signaling protects retina from nuclear factor-κB- and poly-ADP-ribose-polymerase-mediated apoptosis under high-glucose stimulation.
Qin X; Zhang Z; Xu H; Wu Y
Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):703-11. PubMed ID: 21813561
[TBL] [Abstract][Full Text] [Related]
23. Polyphenol-enriched cocoa protects the diabetic retina from glial reaction through the sirtuin pathway.
Duarte DA; Rosales MA; Papadimitriou A; Silva KC; Amancio VH; Mendonça JN; Lopes NP; de Faria JB; de Faria JM
J Nutr Biochem; 2015 Jan; 26(1):64-74. PubMed ID: 25448608
[TBL] [Abstract][Full Text] [Related]
24. The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X Receptor.
Hammer SS; Beli E; Kady N; Wang Q; Wood K; Lydic TA; Malek G; Saban DR; Wang XX; Hazra S; Levi M; Busik JV; Grant MB
EBioMedicine; 2017 Aug; 22():181-190. PubMed ID: 28774737
[TBL] [Abstract][Full Text] [Related]
25. SIRT1 regulates TNF-α-induced expression of CD40 in 3T3-L1 adipocytes via NF-κB pathway.
Lin QQ; Yan CF; Lin R; Zhang JY; Wang WR; Yang LN; Zhang KF
Cytokine; 2012 Nov; 60(2):447-55. PubMed ID: 22717288
[TBL] [Abstract][Full Text] [Related]
26. The role of SIRT1 in diabetic retinopathy.
Karbasforooshan H; Karimi G
Biomed Pharmacother; 2018 Jan; 97():190-194. PubMed ID: 29091865
[TBL] [Abstract][Full Text] [Related]
27. Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition.
Chen XL; Zhang XD; Li YY; Chen XM; Tang DR; Ran RJ
Br J Ophthalmol; 2013 Dec; 97(12):1598-603. PubMed ID: 24133029
[TBL] [Abstract][Full Text] [Related]
28. SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1.
Mortuza R; Feng B; Chakrabarti S
J Cell Mol Med; 2015 Aug; 19(8):1857-67. PubMed ID: 25753689
[TBL] [Abstract][Full Text] [Related]
29. Fasting and fasting-mimicking treatment activate SIRT1/LXRα and alleviate diabetes-induced systemic and microvascular dysfunction.
Hammer SS; Vieira CP; McFarland D; Sandler M; Levitsky Y; Dorweiler TF; Lydic TA; Asare-Bediako B; Adu-Agyeiwaah Y; Sielski MS; Dupont M; Longhini AL; Li Calzi S; Chakraborty D; Seigel GM; Proshlyakov DA; Grant MB; Busik JV
Diabetologia; 2021 Jul; 64(7):1674-1689. PubMed ID: 33770194
[TBL] [Abstract][Full Text] [Related]
30. Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.
Kowluru RA; Santos JM; Zhong Q
Invest Ophthalmol Vis Sci; 2014 Jun; 55(9):5653-60. PubMed ID: 24894401
[TBL] [Abstract][Full Text] [Related]
31. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
[TBL] [Abstract][Full Text] [Related]
32. Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1.
Liu HN; Cao NJ; Li X; Qian W; Chen XL
Biochem Biophys Res Commun; 2018 Nov; 505(4):1236-1243. PubMed ID: 30333091
[TBL] [Abstract][Full Text] [Related]
33. UPP mediated Diabetic Retinopathy via ROS/PARP and NF-κB inflammatory factor pathways.
Luo DW; Zheng Z; Wang H; Fan Y; Chen F; Sun Y; Wang WJ; Sun T; Xu X
Curr Mol Med; 2015; 15(8):790-9. PubMed ID: 26391545
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome Proliferator-Activated Receptor α Facilitates Osteogenic Differentiation in MC3T3-E1 Cells via the Sirtuin 1-Dependent Signaling Pathway.
Gong K; Qu B; Wang C; Zhou J; Liao D; Zheng W; Pan X
Mol Cells; 2017 Jun; 40(6):393-400. PubMed ID: 28614912
[TBL] [Abstract][Full Text] [Related]
35. Gliquidone improves retinal injury to relieve diabetic retinopathy via regulation of SIRT1/Notch1 pathway.
Yu M; Zhang L; Sun S; Zhang Z
BMC Ophthalmol; 2021 Dec; 21(1):451. PubMed ID: 34961513
[TBL] [Abstract][Full Text] [Related]
36. Sirt1: A Guardian of the Development of Diabetic Retinopathy.
Mishra M; Duraisamy AJ; Kowluru RA
Diabetes; 2018 Apr; 67(4):745-754. PubMed ID: 29311218
[TBL] [Abstract][Full Text] [Related]
37. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
38. Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells.
Dragomir E; Tircol M; Manduteanu I; Voinea M; Simionescu M
Vascul Pharmacol; 2006 Jun; 44(6):440-9. PubMed ID: 16600694
[TBL] [Abstract][Full Text] [Related]
39. tiRNA-Val promotes angiogenesis via Sirt1-Hif-1α axis in mice with diabetic retinopathy.
Xu Y; Zou H; Ding Q; Zou Y; Tang C; Lu Y; Xu X
Biol Res; 2022 Mar; 55(1):14. PubMed ID: 35346383
[TBL] [Abstract][Full Text] [Related]
40. Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy.
Mishra M; Kowluru RA
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1761-1769. PubMed ID: 28478229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
